Bruker Corporation (BRKR)

Market Cap	9.33B
Revenue (ttm)	3.00B
Net Income (ttm)	401.60M
Shares Out	151.34M
EPS (ttm)	2.74
PE Ratio	22.50
Forward PE	20.59
Dividend	$0.20 (0.32%)
Ex-Dividend Date	Jun 3, 2024

Volume	798,457
Open	62.33
Previous Close	62.33
Day's Range	61.59 - 62.92
52-Week Range	53.79 - 94.86
Beta	1.25
Analysts	Buy
Price Target	85.71 (+39.05%)
Earnings Date	Aug 1, 2024

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related te...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 9,707
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR

Financial Performance

In 2023, Bruker's revenue was $2.96 billion, an increase of 17.14% compared to the previous year's $2.53 billion. Earnings were $427.20 million, an increase of 44.03%.

Analyst Forecast

According to 8 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $85.71, which is an increase of 39.05% from the latest price.

Price Target

$85.71

(39.05% upside)

Analyst Consensus: Buy